About a-team Marketing Services
The knowledge platform for the financial technology industry
The knowledge platform for the financial technology industry

A-Team Insight Blogs

Talking Reference Data with Andrew Delaney: How to Profit from LEI

Subscribe to our newsletter

As predicted here, the Summer of LEI continues unabated. Returning from a couple of weeks in the Mediterranean – now on a diet – I read with interest our own Sarah Underwood’s account of the Financial Stability Board’s inaugural Legal Entity Identifier (LEI) Private Sector Preparatory Group (PSPG), and settled down to catch up on the latest supply-side missive on the topic: this time from Thomson Reuters.

You can read global head of legal entity content Tim Lind’s paper – titled Legal Entity Data: Mapping the Corporate Genome – by downloading it for free below. What struck me about the piece – aside from Tim’s usual rigorous treatment of the topic – was its perhaps-contrarian, bright outlook for those practitioners embracing the standard.

Lind’s paper is striking in the way that it places the LEI at the centre of the universe. His words: “We are entering a new phase in the evolution of financial data and a potential renaissance in the approach to risk management. Legal entity data will be the core building block of this renaissance.” Stirring stuff.

But whereas many industry commentators have focused on the ‘stick’ element of the need for a standard entity identifier – how failing to settle on an agreed approach will result in dire consequences of Lehman-like proportions – Lind’s paper takes a stab at identifying the ‘carrot’.

“It would be a mistake,” he writes, “to overlook the potential predictive value of legal entity data in terms of discovering revenue opportunity and supporting investment and trading positions.” In other words, this is not about mopping up after the act; it’s about pre-trade analysis of a sort.

Lind goes on to illustrate this potential through the analogy of the human genome. It’s one we’ve pondered in the past, especially since our old boss, Dennis Waters, decided to ditch the familiar world of financial technology (he sold us to Risk Magazine for $13 million) to embrace all things genome: take a look at www.genomeweb.com if this floats your boat.

In Lind’s view, the science of the human genome – and how relationships between component parts can help predict, say, how vulnerable an organism is to a specific disease – illustrates how important definition and documentation is to the science of prediction in financial markets: “To advance our understanding of credit and market risk, we first must map and document the core reference data of the corporate genome.”

Pre-Lehman and beyond, “Many firms struggled with how they uniquely identify an entity, its core attributes, their corporate hierarchy, and how to link entities to outstanding positions, transactions and other data used to assess counterparty and credit risk.” I think you get where he is going with this.

Lind’s paper goes on to talk about how various regulations are driving the need for something – something – to meet this need, and offers Thomson Reuters’ vision for creating an entity- rather than security-centric view of the world. He provides a useful check-list of the adjacent data sets that Thomson Reuters believes legal entities should link to: something, surely, to cut out and keep, and possibly stick to the fridge with a magnet (or maybe not).

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: How to leverage data lineage for actionable business insights

Data lineage is a must-have for financial institutions, but is it being used to its greatest extent, and is it delivering actionable business insights that inform product development and support competitive advantage? This webinar will address these questions, looking first at the status quo of data lineage across capital markets, and moving on to discuss...

BLOG

Beyond Licence Fees: Key Considerations for Lowering TCO in Financial Data Management

By Neil Sandle, Chief Product Officer, Alveo. New technologies can significantly reduce the total cost of ownership (TCO) for financial data management platforms, with considerations going beyond the vendor licence fee and encompassing the full scope of TCO. Understanding your data management TCO requires evaluating key factors with solution providers, including the technology stack’s quality,...

EVENT

Buy AND Build: The Future of Capital Markets Technology, London

Buy AND Build: The Future of Capital Markets Technology London on September 19th at Marriott Hotel Canary Wharf London examines the latest changes and innovations in trading technology and explores how technology is being deployed to create an edge in sell side and buy side capital markets financial institutions.

GUIDE

Regulatory Data Handbook 2023 – Eleventh Edition

Welcome to the eleventh edition of A-Team Group’s Regulatory Data Handbook, a popular publication that covers new regulations in capital markets, tracks regulatory change, and provides advice on the data, data management and implementation requirements of more than 30 regulations across UK, European, US and Asia-Pacific capital markets. This edition of the handbook includes new...